Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products von O’Brien Gore, Charlotte, Billman, Amy, Hunjan, Suchete, Colebrook, Jayne, Choy, Desmond, Li, Wilson, Haynes, Jack, Wade, Jennifer, Hobern, Emily, McDonald, Louisa, Papa, Sophie, Brugman, Martijn, Kordasti, Shahram, Montiel-Equihua, Claudia

Volltext

BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity von Westaby, Daniel, Jiménez-Vacas, Juan M, Figueiredo, Ines, Rekowski, Jan, Pettinger, Claire, Gurel, Bora, Lundberg, Arian, Bogdan, Denisa, Buroni, Lorenzo, Neeb, Antje, Padilha, Ana, Taylor, Joe, Zeng, Wanting, Das, Souvik, Hobern, Emily, Riisnaes, Ruth, Crespo, Mateus, Miranda, Susana, Ferreira, Ana, Hanratty, Brian P, Nava Rodrigues, Daniel, Bertan, Claudia, Seed, George, Fenor de La Maza, Maria de Los Dolores, Guo, Christina, Carmichael, Juliet, Grochot, Rafael, Chandran, Khobe, Stavridi, Anastasia, Varkaris, Andreas, Stylianou, Nataly, Hollier, Brett G, Tunariu, Nina, Balk, Steven P, Carreira, Suzanne, Yuan, Wei, Nelson, Peter S, Corey, Eva, Haffner, Michael, de Bono, Johann, Sharp, Adam

Volltext